BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38684343)

  • 1. Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Shi V; Grover S; Huang Y; Thaker PH; Kuroki LM; Powell MA; Mutch DG; Contreras JA; Schwarz JK; Grigsby PW; Markovina S
    Int J Gynecol Cancer; 2024 Apr; ():. PubMed ID: 38684343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma antigen isoforms in serum from cervical cancer patients.
    Roijer E; de Bruijn HW; Dahlén U; ten Hoor K; Lundin M; Nilsson K; Soderstrom K; Nilsson O
    Tumour Biol; 2006; 27(3):142-52. PubMed ID: 16641548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
    Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
    Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in serum squamous cell carcinoma antigen levels after surgery in patients with sinonasal inverted papilloma.
    Kitamura Y; Kamimura S; Fujii T; Kanamura R; Fukuda J; Kondo E; Azuma T; Sato G; Takeda N
    Auris Nasus Larynx; 2022 Aug; 49(4):697-702. PubMed ID: 34996617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
    Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.
    Ran C; Sun J; Qu Y; Long N
    World J Surg Oncol; 2021 Dec; 19(1):343. PubMed ID: 34886853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anti-squamous cell carcinoma antigen antibodies on serum squamous cell carcinoma antigen levels measured by chemiluminescent immunoassay and chemiluminescent enzyme immunoassay.
    Oyabu C; Sato I; Yamamoto M; Imanishi T; Sendo S; Yano Y
    Lab Med; 2024 May; 55(3):341-346. PubMed ID: 37706549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
    Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma.
    Bolger BS; Dabbas M; Lopes A; Monaghan JM
    Gynecol Oncol; 1997 May; 65(2):309-13. PubMed ID: 9159343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer.
    Hu YY; Fan W; Zhang X; Liang PY; Lin XP; Zhang YR; Li YH
    J Cancer; 2015; 6(3):287-91. PubMed ID: 25663947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Cervical Squamous Cell Carcinoma Concurrent with Sinonasal Inverted Papilloma: A Case Report.
    Hou XY; Peng CR; Zhang GN; Wang DF
    Int J Womens Health; 2022; 14():1657-1666. PubMed ID: 36471668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative value of serum squamous cell carcinoma antigen as a predictor of recurrence in sinonasal inverted papilloma.
    van Zijl FVWJ; Monserez DA; Korevaar TIM; Bugter O; Wieringa MH; Baatenburg de Jong RJ; Hardillo JAU
    Clin Otolaryngol; 2017 Jun; 42(3):528-535. PubMed ID: 27717197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen.
    Yuan SH; Liang XF; Jia WH; Huang JL; Wei M; Deng L; Liang LZ; Wang XY; Zeng YX
    Clin Cancer Res; 2008 Sep; 14(17):5571-8. PubMed ID: 18765550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.
    Huang XD; Huo LQ; Luo YS; Chen K; Li JY; Shi L; Huang L; Cao XP; Ou-Yang Y; Chen FP
    Ther Adv Med Oncol; 2023; 15():17588359231165974. PubMed ID: 37025259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
    BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.